{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:45:32Z","timestamp":1790516732127,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.pathol.2019.09.006","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T08:38:28Z","timestamp":1573029508000},"page":"40-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Epstein\u2013Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review"],"prefix":"10.1016","volume":"52","author":[{"given":"Mario L.","family":"Marques-Piubelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yessenia I.","family":"Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4633-4618","authenticated-orcid":false,"given":"Carlos","family":"Pachas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4293-5704","authenticated-orcid":false,"given":"Renato","family":"Becker-Hecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5956-452X","authenticated-orcid":false,"given":"Francisco","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2019.09.006_bib1","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1128\/jvi.61.5.1416-1420.1987","article-title":"Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV\/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d","volume":"61","author":"Nemerow","year":"1987","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.pathol.2019.09.006_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-pathmechdis-012418-013023","article-title":"Epstein-Barr virus and cancer","volume":"14","author":"Farrell","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The immunology of Epstein-Barr virus-induced disease","volume":"33","author":"Taylor","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.pathol.2019.09.006_bib4","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/art.1780400621","article-title":"Epstein-Barr virus strain type and latent membrane protein 1 gene deletions in lymphomas in patients with rheumatic diseases","volume":"40","author":"Natkunam","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pathol.2019.09.006_bib5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pathol.2019.09.006_bib6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.4459","article-title":"The Epstein-Barr virus and the pathogenesis of lymphoma","volume":"235","author":"Vockerodt","year":"2015","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib7","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1158\/1078-0432.CCR-10-2578","article-title":"Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes","volume":"17","author":"Saha","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2019.09.006_bib8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bjs.18004619704","article-title":"A\u00a0sarcoma involving the jaws in African children","volume":"46","author":"Burkitt","year":"1958","journal-title":"Br J Surg"},{"key":"10.1016\/j.pathol.2019.09.006_bib9","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","article-title":"Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma","volume":"133","author":"Grande","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.006_bib10","first-page":"330","article-title":"Burkitt lymphoma","author":"Leoncini","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.006_bib11","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","article-title":"Burkitt's lymphoma","volume":"379","author":"Molyneux","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pathol.2019.09.006_bib12","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.MP.0000019577.73786.64","article-title":"The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement","volume":"15","author":"Nakamura","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib13","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/modpathol.2010.76","article-title":"Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas","volume":"23","author":"Seegmiller","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2559.2008.02974.x","article-title":"Sporadic paediatric and adult Burkitt lymphomas share similar phenotypic and genotypic features","volume":"52","author":"Chuang","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.006_bib15","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1309\/EQJR3D3V0CCQGP04","article-title":"Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH","volume":"128","author":"Chuang","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0000000000000332","article-title":"Epstein-Barr virus (EBV)-positive sporadic Burkitt lymphoma: an age-related lymphoproliferative disorder?","volume":"39","author":"Satou","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib17","article-title":"Beyond endemic Burkitt lymphoma: navigating challenges of differentiating childhood lymphoma diagnoses amid limitations in pathology resources in Lilongwe, Malawi","volume":"4","author":"El-Mallawany","year":"2017","journal-title":"Glob Pediatr Health"},{"key":"10.1016\/j.pathol.2019.09.006_bib18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/PAS.0000000000000804","article-title":"Prognostic impact of MUM1\/IRF4 expression in Burkitt lymphoma (BL): a reappraisal of 88 BL patients in Japan","volume":"41","author":"Satou","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.humpath.2008.07.021","article-title":"Frequent expression of multiple myeloma 1\/interferon regulatory factor 4 in Burkitt lymphoma","volume":"40","author":"Gualco","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib20","doi-asserted-by":"crossref","first-page":"14935","DOI":"10.1073\/pnas.0509988103","article-title":"Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells","volume":"103","author":"Kelly","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2019.09.006_bib21","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/modpathol.2017.58","article-title":"Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms","volume":"30","author":"Onaindia","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1309\/AJCPYP00JNUFWCCY","article-title":"Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia\/lymphoma and Burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker","volume":"133","author":"Nasr","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib23","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3109\/10428194.2015.1076928","article-title":"EBV-associated Burkitt lymphoma in Taiwan is not age-related","volume":"57","author":"Chen","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2019.09.006_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.clml.2016.04.011","article-title":"Clinical implications of CD30 expression in aggressive B-cell lymphomas","volume":"16","author":"Malysz","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.pathol.2019.09.006_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1472-6890-9-11","article-title":"Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda","volume":"9","author":"Tumwine","year":"2009","journal-title":"BMC Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib26","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1365-2141.2011.09013.x","article-title":"Epidemiology: clues to the pathogenesis of Burkitt lymphoma","volume":"156","author":"Magrath","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.006_bib27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2019.09.006_bib28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","article-title":"Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients","volume":"27","author":"Oyama","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib29","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1158\/1078-0432.CCR-06-2823","article-title":"Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients","volume":"13","author":"Oyama","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2019.09.006_bib30","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","article-title":"EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment","volume":"126","author":"Nicolae","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.006_bib31","doi-asserted-by":"crossref","first-page":"13933","DOI":"10.18632\/oncotarget.4324","article-title":"Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?","volume":"6","author":"Ok","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2019.09.006_bib32","doi-asserted-by":"crossref","first-page":"12168","DOI":"10.1038\/srep12168","article-title":"Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age","volume":"5","author":"Lu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.pathol.2019.09.006_bib33","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.humpath.2015.01.011","article-title":"Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly","volume":"46","author":"Uccini","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib34","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/modpathol.2012.52","article-title":"EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation","volume":"25","author":"Montes-Moreno","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib35","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1158\/1078-0432.CCR-13-3157","article-title":"Prevalence and clinical implications of Epstein-Barr virus infection in de novo diffuse large B-cell lymphoma in Western countries","volume":"20","author":"Ok","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2019.09.006_bib36","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2002-02-0487","article-title":"KSHV- and EBV-associated germinotropic lymphoproliferative disorder","volume":"100","author":"Du","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.006_bib37","first-page":"325","article-title":"HHV8-associated lymphoproliferative disorders","author":"Said","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.006_bib38","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1080\/10428190701387039","article-title":"KSHV- and EBV-associated germinotropic lymphoproliferative disorder: a rare lymphoproliferative disease of HIV patient with plasmablastic morphology, indolent course and favourable response to therapy","volume":"48","author":"D'Antonio","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2019.09.006_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12185-011-0975-8","article-title":"A\u00a0case of successful management of HHV-8(+), EBV(+) germinotropic lymphoproliferative disorder (GLD)","volume":"95","author":"Oh","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.pathol.2019.09.006_bib40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.annpat.2014.06.013","article-title":"KHSV\/EBV associated germinotropic lymphoproliferative disorder: a rare entity, case report and review of the literature. (French)","volume":"34","author":"Taris","year":"2014","journal-title":"Ann Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib41","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.humpath.2015.06.020","article-title":"Rare variants in the spectrum of human herpesvirus 8\/Epstein-Barr virus-copositive lymphoproliferations","volume":"46","author":"Papoudou-Bai","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib42","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1309\/AJCPULI3W6WUGGPY","article-title":"Diverse clinicopathologic features in human herpesvirus 8-associated lymphomas lead to diagnostic problems","volume":"142","author":"Courville","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib43","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/modpathol.2016.233","article-title":"HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma","volume":"30","author":"Gonzalez-Farre","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib44","first-page":"1578429","article-title":"HHV8\/EBV coinfection lymphoproliferative disorder: rare entity with a favorable outcome","volume":"2017","author":"Bacha","year":"2017","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.pathol.2019.09.006_bib45","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/PAS.0000000000000823","article-title":"KSHV-associated and EBV-associated germinotropic lymphoproliferative disorder: new findings and review of the literature","volume":"41","author":"Bhavsar","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib46","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.pathol.2017.03.003","article-title":"PD-L1 and Notch1 expression in KSHV\/HHV-8 and EBV associated germinotropic lymphoproliferative disorder: case report and review of the literature","volume":"49","author":"Ronaghy","year":"2017","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2019.09.006_bib47","first-page":"358","article-title":"EBV-positive T-cell and NK-cell lymphoproliferative disease of childhood","author":"Quintanilla-Martinez","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.006_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fped.2019.00071","article-title":"Epstein-Barr virus-associated T and NK-cell lymphoproliferative diseases","volume":"7","author":"Kim","year":"2019","journal-title":"Front Pediat"},{"key":"10.1016\/j.pathol.2019.09.006_bib49","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","article-title":"Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States","volume":"117","author":"Cohen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.006_bib50","first-page":"444","article-title":"Lymphoproliferative diseases associated with primary immune disorders","author":"van Krieken","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.006_bib51","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jaci.2011.02.047","article-title":"Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies","volume":"127","author":"Rezaei","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.pathol.2019.09.006_bib52","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/bjh.12422","article-title":"Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases","volume":"162","author":"Parvaneh","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.006_bib53","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1128\/JVI.03001-14","article-title":"Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines","volume":"89","author":"Coleman","year":"2015","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.pathol.2019.09.006_bib54","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/00000478-199212000-00004","article-title":"Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome","volume":"16","author":"Sander","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib55","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.pathol.2019.09.006_bib56","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/j.seminoncol.2014.12.029","article-title":"The epidemiology of cancers in human immunodeficiency virus infection and after organ transplantation","volume":"42","author":"Grulich","year":"2015","journal-title":"Sem Oncol"},{"key":"10.1016\/j.pathol.2019.09.006_bib57","first-page":"449","article-title":"Lymphomas associated with HIV infection","author":"Said","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.006_bib58","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/IJPM.IJPM_452_17","article-title":"HIV-associated lymphoma: a 5-year clinicopathologic study from India","volume":"62","author":"Sampath","year":"2019","journal-title":"Ind J Pathol Microbiol"},{"key":"10.1016\/j.pathol.2019.09.006_bib59","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12185-019-02668-0","article-title":"The current state of human immunodeficiency virus-associated lymphoma in Japan: a nationwide retrospective study of the Japanese Society of Hematology Blood Disease Registry","volume":"110","author":"Hagiwara","year":"2019","journal-title":"Int J Hematol"},{"key":"10.1016\/j.pathol.2019.09.006_bib60","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrclinonc.2014.31","article-title":"Diagnosis and management of lymphomas and other cancers in HIV-infected patients","volume":"11","author":"Carbone","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.006_bib61","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5858\/arpa.2012-0095-RA","article-title":"Lymphoid proliferations associated with human immunodeficiency virus infection","volume":"137","author":"Chadburn","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2019.09.006_bib62","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.semcancer.2013.08.004","article-title":"Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology","volume":"23","author":"Gloghini","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.pathol.2019.09.006_bib63","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.4049\/jimmunol.172.11.6931","article-title":"Altered EBV viral load setpoint after HIV seroconversion is in accordance with lack of predictive value of EBV load for the occurrence of AIDS-related non-Hodgkin lymphoma","volume":"172","author":"Piriou","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pathol.2019.09.006_bib64","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1086\/341460","article-title":"Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma","volume":"186","author":"Van Baarle","year":"2002","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.pathol.2019.09.006_bib65","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1111\/j.1600-6143.2009.02781.x","article-title":"Activation of the JAK\/STAT pathway in Epstein Barr virus+-associated posttransplant lymphoproliferative disease: role of interferon-gamma","volume":"9","author":"Vaysberg","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.pathol.2019.09.006_bib66","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JVI.01512-10","article-title":"A\u00a0new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas","volume":"85","author":"Ma","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.pathol.2019.09.006_bib67","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/j.semdp.2017.04.003","article-title":"Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point","volume":"34","author":"Linke-Serinsoz","year":"2017","journal-title":"Sem Diagn Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib68","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2141.2005.05613.x","article-title":"AIDS-related lymphomas: from pathogenesis to pathology","volume":"130","author":"Carbone","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.006_bib69","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/bmj.4.5633.746","article-title":"Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy","volume":"4","author":"Doak","year":"1968","journal-title":"Br Med J"},{"key":"10.1016\/j.pathol.2019.09.006_bib70","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11899-013-0162-5","article-title":"Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies","volume":"8","author":"Al-Mansour","year":"2013","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.pathol.2019.09.006_bib71","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(84)90994-2","article-title":"Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy","volume":"1","author":"Starzl","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.pathol.2019.09.006_bib72","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-3-319-13150-4_13","article-title":"Post-transplant lymphoproliferative disorders","volume":"165","author":"Singavi","year":"2015","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.pathol.2019.09.006_bib73","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.5858\/2007-131-1209-TCSOPL","article-title":"The clinicopathologic spectrum of posttransplantation lymphoproliferative disorders","volume":"131","author":"Tsao","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2019.09.006_bib74","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/cncr.31339","article-title":"Impact of the posttransplant lymphoproliferative disorder subtype on survival","volume":"124","author":"Koff","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2019.09.006_bib75","doi-asserted-by":"crossref","first-page":"505","DOI":"10.5500\/wjt.v6.i3.505","article-title":"Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders","volume":"6","author":"Morscio","year":"2016","journal-title":"World J Transpl"},{"key":"10.1016\/j.pathol.2019.09.006_bib76","doi-asserted-by":"crossref","first-page":"150835","DOI":"10.1155\/2013\/150835","article-title":"Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?","volume":"2013","author":"Morscio","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.pathol.2019.09.006_bib77","first-page":"462","article-title":"Other iatrogenic immunodeficiency associated lymphoproliferative disorders","author":"Gaulard","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.006_bib78","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/modpathol.2009.131","article-title":"Immunomodulator agent-related lymphoproliferative disorders","volume":"22","author":"Hasserjian","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib79","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/annonc\/mdu365","article-title":"Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study","volume":"25","author":"Fallah","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pathol.2019.09.006_bib80","first-page":"1172","article-title":"Complications of immunosuppression associated with weekly low dose methotrexate","volume":"18","author":"Shiroky","year":"1991","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.pathol.2019.09.006_bib81","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199305063281806","article-title":"Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis","volume":"328","author":"Kamel","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2019.09.006_bib82","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archderm.1997.03890430083011","article-title":"Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis","volume":"133","author":"Paul","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.pathol.2019.09.006_bib83","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jbspin.2017.01.006","article-title":"EBV-induced lymphoproliferative disorders in rheumatic patients: a systematic review of the literature","volume":"85","author":"Berti","year":"2018","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.pathol.2019.09.006_bib84","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/art.10939","article-title":"Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives","volume":"48","author":"Ekstrom","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pathol.2019.09.006_bib85","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semcancer.2013.12.001","article-title":"Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces?","volume":"24","author":"Baecklund","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.pathol.2019.09.006_bib86","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ejh.12116","article-title":"Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression","volume":"91","author":"Ichikawa","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.pathol.2019.09.006_bib87","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1097\/PAS.0000000000000095","article-title":"Iatrogenic immunodeficiency-associated classical Hodgkin lymphoma: clinicopathologic features of 54 cases reported in the literature","volume":"37","author":"Miranda","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib88","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/his.12627","article-title":"Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders","volume":"67","author":"Yamada","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.006_bib89","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3899\/jrheum.130270","article-title":"A\u00a0clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders","volume":"41","author":"Yamakawa","year":"2014","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.pathol.2019.09.006_bib90","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib91","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"307","article-title":"EBV-positive mucocutaneous ulcer","author":"Gaulard","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.006_bib92","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40164-016-0042-5","article-title":"Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a case report and systematic review of the literature","volume":"5","author":"Roberts","year":"2015","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.pathol.2019.09.006_bib93","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/PAS.0000000000000282","article-title":"EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder","volume":"38","author":"Hart","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib94","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/bmt.2015.245","article-title":"Presentation and management of post-allogeneic transplantation EBV-positive mucocutaneous ulcer","volume":"51","author":"Nelson","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.pathol.2019.09.006_bib95","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12105-010-0202-6","article-title":"Methotrexate-related Epstein-Barr Virus (EBV)-associated lymphoproliferative disorder--so-called \u201cHodgkin-like lesion\u201d--of the oral cavity in a patient with rheumatoid arthritis","volume":"4","author":"Kikuchi","year":"2010","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib96","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.oooo.2015.06.028","article-title":"EBV-positive mucocutaneous ulcer of the oral cavity associated with HIV\/AIDS","volume":"120","author":"Bunn","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.pathol.2019.09.006_bib97","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00428-011-1064-3","article-title":"Iatrogenic EBV-positive lymphoproliferative disorder with features of EBV+ mucocutaneous ulcer: evidence for concomitant TCRgamma\/IGH rearrangements in the Hodgkin-like neoplastic cells","volume":"458","author":"Di Napoli","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2019.09.006_bib98","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.3748\/wjg.v21.i19.6072","article-title":"Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn's disease","volume":"21","author":"Moran","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pathol.2019.09.006_bib99","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1600-0560.2011.01829.x","article-title":"Azathioprine-induced EBV-positive mucocutaneous ulcer","volume":"39","author":"McGinness","year":"2012","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.pathol.2019.09.006_bib100","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1038\/emm.2014.82","article-title":"EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management","volume":"47","author":"Ok","year":"2015","journal-title":"Exp Mol Med"}],"updated-by":[{"DOI":"10.1016\/j.pathol.2026.08.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000}}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519303964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519303964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:26:01Z","timestamp":1758471961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302519303964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0031302519303964"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2019.09.006","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein\u2013Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2019.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}